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Background
To achieve statistical significance in rare disease research,
bio- or data samples taken from one patient registry or
biobank may need to be complemented by those of other
institutions [1,2]. While a first overview of potential
research partners can be obtained using public catalogues
as established by BBMRI [3] or Orphanet [4], this article
focuses on mediation services, which provide deeper
insight on available material using criteria-based search on
fine-grained, non-aggregated datasets. Until now, these
datasets were provided either beforehand via regular
uploads (central search, e.g. CRIP [5] and the NCI’s speci-
men resource locator [6]) or on-demand via distributed
queries (federated search, e.g. i2b2 SHRINE [7] and
EHR4CR [8]). However, both ways give third parties
whom the data or sample owners may neither know nor
trust insight into their databases.
The requirement for self-disclosure places owners in a
dilemma: On the one hand, they want to contribute to
promising collaborative research projects. On the other
hand, they “frequently hold proprietary views on their
data” [9] and want to carefully consider with whom to
share their assets collected over years without facing
pressure of justification for rejecting a proposal.
Results
We propose a method to search distributed databases, yet
fully keep their owner’s data sovereignty: The decentral
search exploits distributed, heterogeneous, highly sensitive
datasets from equally heterogeneous systems for over-
arching research questions. Similar to other federated
searches, the decentral search detects matching material
in distributed data stocks. However, their query mechan-
ism is replaced by a novel request mechanism that
involves the owner with a high degree of control, who
can (decentrally using their own registry or biobank
systems) decide if and what to answer based on a specific
project proposal. As no datasets ever leave their institu-
tion, they can reject projects without risking their good
standing as a cooperative scientist. While the decentral
search sacrifices real-time answers, it leads to several
beneficial side effects: improved data protection due to
data parsimony, tolerance for incomplete data schema
mappings, flexibility with regard to patient consents and
decreased effort when the network is initially joined.
Conclusion
The decentral search allows to exploit bio- or data samples
while fully preserving their owners’ data sovereignty. It is
employed in the Consortium for Translational Cancer
Research, one of the six German Centres for Health
Research comprised of eleven university hospitals. The
decentral search also marks the centrepiece of the OSSE
national registry of rare diseases.
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